Endovascular management of acute ischemic stroke

Neurosurgical Focus

Volumn 26, Issue 3, 2009, Pages 1-8

  Gandhi, Chirag D ^a   Christiano, Land D ^a   Prestigiacomo, Charles J ^a  

^a University of Medicine and Dentistry of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTITHROMBOCYTIC AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; TISSUE PLASMINOGEN ACTIVATOR;

ANGIOPLASTY; FIBRINOLYTIC THERAPY; HUMAN; INSTRUMENTATION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVIEW; STENT; STROKE; THROMBECTOMY; TIME;

ANGIOPLASTY; ANGIOPLASTY, BALLOON; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INFUSIONS, INTRAVENOUS; PLATELET AGGREGATION INHIBITORS; STENTS; STROKE; THROMBECTOMY; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 70349732072     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2009.1.focus08275     Document Type: Article

References (34)

1. The Abciximab in Ischemic Stroke Investigators: Abciximab in acute ischemic stroke: a randomized, double-blind, placebocontrolled, dose-escalation study. Stroke 31:601-609, 2000
2. Alexander MJ, Duckwiler GR, Gobin YP, Vinuela F: Management of intraprocedural arterial thrombus in cerebral aneurysm embolization with abciximab: technical case report. Neurosurgery 50:899-902, 2002
3. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM: Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology 56:1015-1020, 2001
4. Bose A, Henkes H, Alfke K, Mayer TE, Berlis A, Branca V, Po Sit S: The Penumbra System: a mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 29:1409-1413, 2008
5. Felberg RA, Okon NJ, El-Mitwalli A, Burgin WS, Grotta JC, Alexandrov AV: Early dramatic recovery during intravenous tissue plasminogen activator infusion: clinical pattern and outcome in acute middle cerebral artery stroke. Stroke 33:1301-1307, 2002
6. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282:2003-2011, 1999
7. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, et al: Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 341:1949-1956, 1999
8. Haley EC Jr, Lewandowski C, Tilley BC: Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight. Ann Emerg Med 30:676-682, 1997
9. Henkes H, Miloslavski E, Lowens S, Reinartz J, Liebig T, Kuhne D: Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 47:222-228, 2005
10. Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, et al: Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 34:e109-e137, 2003
11. The Interventional Management of Stroke Study Investigators: Combined intravenous and intra-arterial recanalization for acute ischemic stroke. Stroke 35:904-911, 2004
12. The Interventional Management of Stroke Study Investigators: Hemorrhage in the Interventional Management of Stroke study: Stroke 37:847-851, 2006
13. Kapadia SR, Bajzer CT, Ziada KM, Bhatt DL, Wazni OM, Silver MJ, et al: Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy. Stroke 32:2328-2332, 2001
14. Katz JM, Gobin YP: Merci Retriever in acute stroke treatment. Expert Rev Med Devices 3:273-280, 2006
15. Keris V, Rudnicka S, Vorona V, Enina G, Tilgale B, Fricbergs J: Combined intraarterial/intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 22:352-358, 2001
16. Kim DJ, Kim DI, Kim SH, Lee KY, Heo JH, Han SW: Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy. Neuroradiology 47:616-621, 2005
17. Labiche LA, Al-Senani F, Wojner AW, Grotta JC, Malkoff M, Alexandrov AV: Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 34:695-698, 2003
18. Lee DH, Jo KD, Kim HG, Choi SJ, Jung SM, Ryu DS, et al: Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study. J Vasc Interv Radiol 13:769-774, 2002
19. Levy EI, Ecker RD, Horowitz MB, Gupta R, Hanel RA, Sauvageau E, et al: Stent-assisted intracranial recanalization for acute stroke: early results. Neurosurgery 58:458-463, 2006
20. Lum C, Stys PK, Hogan MJ, Nguyen TB, Srinivasan A, Goyal M: Acute anterior circulation stroke: recanalization using clot angioplasty. Can J Neurol Sci 33:217-222, 200621.
21. Nakano S, Iseda T, Yoneyama T, Kawano H, Wakisaka S: Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intraarterial thrombolysis. Stroke 33:2872-2876, 2002
22. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587, 1995
23. Pessin MS, del Soppo GJ, Furlan AJ: Thrombolytic treatment in acute stroke: review and update of selective topics, in Moskowitz M, Calplan LR (eds): Cerebrovascular Diseases: Nineteenth Princeton Review Stroke Conference. Boston, MA: Butterworth-Heinemann, 1995, pp 409-418
24. Qureshi AI, Saad M, Zaidat OO, Suarez JI, Alexander MJ, Fareed M, et al: Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke 33:1916-1919, 2002
25. Ringer AJ, Qureshi AI, Fessler RD, Guterman LR, Hopkins LN: Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 48:1282-1290, 2001
26. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al: Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115:e172, 2007
27. Rubiera M, Alvarez-Sabin J, Ribo M, Montaner J, Santamarina E, Arenillas JF, et al: Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke. Stroke 36:1452-1456, 2005
28. Schellinger PD, Fiebach JB, Mohr A, Ringleb PA, Jansen O, Hacke W: Thrombolytic therapy for ischemic stroke-a review. Part I-Intravenous thrombolysis. Crit Care Med 29:1812-1818, 2001
29. Selco SL, Liebeskind DS: Hyperacute imaging of ischemic stroke: role in therapeutic management. Curr Cardiol Rep 7:10-15, 2005
30. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, et al: Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39:1205-1212, 2008
31. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, et al: Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36:1432-1438, 2005
32. Velat GJ, Burry MV, Eskioglu E, Dettorre RR, Firment CS, Mericle RA: The use of abciximab in the treatment of acute cerebral thromboembolic events during neuroendovascular procedures. Surg Neurol 65:352-359, 2006
33. von Kummer R, Holle R, Rosin L, Forsting M, Hacke W: Does arterial recanalization improve outcome in carotid territory stroke? Stroke 26:581-587, 1995
34. Yoneyama T, Nakano S, Kawano H, Iseda T, Ikeda T, Goya T, et al: Combined direct percutaneous transluminal angioplasty and low-dose native tissue plasminogen activator therapy for acute embolic middle cerebral artery trunk occlusion. AJNR Am J Neuroradiol 23:277-281, 2002